Products

Graphix Link

Visualize your business

graphixlink.app Productivity & Collaboration / Tasks & Project Management

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$42.12/mo
Higher than 90% of peersNiche median $9.72/mo
Creators
Lorenzo Cattaneo
No social account linked
Launched
2y ago
2023-11-30 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    A graph to visualize your business

    Nov 30, 2023 · 2y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2023-11-16

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free Plan
€0/month
Up to 5 nodes · Up to 3 users · 50MB file storage
Pro Plan
€39/month
Unlimited nodes · Up to 30 users · 100GB file storage

Trial: None · Observed 2026-11-07 · Source page

Entry price $42.12/mo, Higher than 90% of peers; “Tasks & Project Management” median is $9.72/mo.View pricing benchmark

Website snapshots

Indexed 2023-11-30

Key pages

Desktop & mobile archive
Home
graphixlink.app/ Snapshot 2026-11-08

Questions & evidence

How much does Graphix Link cost?
Free Plan: €0/month; Pro Plan: €39/month. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Graphix Link get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Graphix Link and what platforms does it support?
Graphix Link is catalogued under Tasks & Project Management: Visualize your business. Supported platforms: Web.

Related products in this category

Productivity & Collaboration / Tasks & Project Management

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.